rRNA methyltransferases and their role in resistance to antibiotics
Methyltransferases (MTases), a large protein superfamily, commonly use S-adenosyl-L-methionine (SAM) as the methyl group donor. SAM-dependant MTases methylate both nucleic acids (DNA, RNA) and proteins, and thus modulate their activity, function and folding. Methylation of G1405 or A1408 nucleotides...
Ausführliche Beschreibung
Autor*in: |
Morić Ivana [verfasserIn] Savić Miloje [verfasserIn] Ilić-Tomić Tatjana [verfasserIn] Vojnović Sandra [verfasserIn] Bajkić Sanja [verfasserIn] Vasiljević Branka [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2010 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Journal of Medical Biochemistry - Society of Medical Biochemists of Serbia, Belgrade, 2008, 29(2010), 3, Seite 165-174 |
---|---|
Übergeordnetes Werk: |
volume:29 ; year:2010 ; number:3 ; pages:165-174 |
Links: |
---|
Katalog-ID: |
DOAJ033016127 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ033016127 | ||
003 | DE-627 | ||
005 | 20230307173709.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230226s2010 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)DOAJ033016127 | ||
035 | |a (DE-599)DOAJ8f959ced14dc422b904dbd3e9c1d7ce7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a QD415-436 | |
100 | 0 | |a Morić Ivana |e verfasserin |4 aut | |
245 | 1 | 0 | |a rRNA methyltransferases and their role in resistance to antibiotics |
264 | 1 | |c 2010 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Methyltransferases (MTases), a large protein superfamily, commonly use S-adenosyl-L-methionine (SAM) as the methyl group donor. SAM-dependant MTases methylate both nucleic acids (DNA, RNA) and proteins, and thus modulate their activity, function and folding. Methylation of G1405 or A1408 nucleotides of 16S rRNA in aminoglycoside-producing microorganisms confers the resistance to their own toxic product(s). This mechanism of resistance has been considered as unique to antibiotics producers until recently. Since 2003, methylation of 16S rRNA as a mechanism of resistance is increasingly emerging in pathogenic bacteria. This represents a major threat towards the usefulness of aminoglycosides in the clinical practice. A potential solution to the problem involves the design of novel compounds that would act against new ribosomal targets. The second approach to the issue includes the development of resistance MTases' inhibitors, with the idea to prevent them from modifying the bacterial rRNA, and thus reinstate the therapeutic power of existing aminoglycosides. As the latter approach has considerable potential, it is obvious that fundamental research related to protein expression, in-depth understanding of the mechanism of action and resolving a tertiary structure of 16S rRNAs MTases are prerequisites for application in medicine. | ||
650 | 4 | |a aminoglycosides | |
650 | 4 | |a methyltransferases | |
650 | 4 | |a resistance | |
650 | 4 | |a ribosome | |
653 | 0 | |a Biochemistry | |
700 | 0 | |a Savić Miloje |e verfasserin |4 aut | |
700 | 0 | |a Ilić-Tomić Tatjana |e verfasserin |4 aut | |
700 | 0 | |a Vojnović Sandra |e verfasserin |4 aut | |
700 | 0 | |a Bajkić Sanja |e verfasserin |4 aut | |
700 | 0 | |a Vasiljević Branka |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Journal of Medical Biochemistry |d Society of Medical Biochemists of Serbia, Belgrade, 2008 |g 29(2010), 3, Seite 165-174 |w (DE-627)557575117 |w (DE-600)2405112-3 |x 14528266 |7 nnns |
773 | 1 | 8 | |g volume:29 |g year:2010 |g number:3 |g pages:165-174 |
856 | 4 | 0 | |u https://doaj.org/article/8f959ced14dc422b904dbd3e9c1d7ce7 |z kostenfrei |
856 | 4 | 0 | |u https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2010/1452-82581003165M.pdf |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1452-8258 |y Journal toc |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1452-8266 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2009 | ||
912 | |a GBV_ILN_2027 | ||
912 | |a GBV_ILN_2055 | ||
912 | |a GBV_ILN_2111 | ||
951 | |a AR | ||
952 | |d 29 |j 2010 |e 3 |h 165-174 |
author_variant |
m i mi s m sm i t t itt v s vs b s bs v b vb |
---|---|
matchkey_str |
article:14528266:2010----::raehlrnfrssnteroeneit |
hierarchy_sort_str |
2010 |
callnumber-subject-code |
QD |
publishDate |
2010 |
allfields |
(DE-627)DOAJ033016127 (DE-599)DOAJ8f959ced14dc422b904dbd3e9c1d7ce7 DE-627 ger DE-627 rakwb eng QD415-436 Morić Ivana verfasserin aut rRNA methyltransferases and their role in resistance to antibiotics 2010 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Methyltransferases (MTases), a large protein superfamily, commonly use S-adenosyl-L-methionine (SAM) as the methyl group donor. SAM-dependant MTases methylate both nucleic acids (DNA, RNA) and proteins, and thus modulate their activity, function and folding. Methylation of G1405 or A1408 nucleotides of 16S rRNA in aminoglycoside-producing microorganisms confers the resistance to their own toxic product(s). This mechanism of resistance has been considered as unique to antibiotics producers until recently. Since 2003, methylation of 16S rRNA as a mechanism of resistance is increasingly emerging in pathogenic bacteria. This represents a major threat towards the usefulness of aminoglycosides in the clinical practice. A potential solution to the problem involves the design of novel compounds that would act against new ribosomal targets. The second approach to the issue includes the development of resistance MTases' inhibitors, with the idea to prevent them from modifying the bacterial rRNA, and thus reinstate the therapeutic power of existing aminoglycosides. As the latter approach has considerable potential, it is obvious that fundamental research related to protein expression, in-depth understanding of the mechanism of action and resolving a tertiary structure of 16S rRNAs MTases are prerequisites for application in medicine. aminoglycosides methyltransferases resistance ribosome Biochemistry Savić Miloje verfasserin aut Ilić-Tomić Tatjana verfasserin aut Vojnović Sandra verfasserin aut Bajkić Sanja verfasserin aut Vasiljević Branka verfasserin aut In Journal of Medical Biochemistry Society of Medical Biochemists of Serbia, Belgrade, 2008 29(2010), 3, Seite 165-174 (DE-627)557575117 (DE-600)2405112-3 14528266 nnns volume:29 year:2010 number:3 pages:165-174 https://doaj.org/article/8f959ced14dc422b904dbd3e9c1d7ce7 kostenfrei https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2010/1452-82581003165M.pdf kostenfrei https://doaj.org/toc/1452-8258 Journal toc kostenfrei https://doaj.org/toc/1452-8266 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2027 GBV_ILN_2055 GBV_ILN_2111 AR 29 2010 3 165-174 |
spelling |
(DE-627)DOAJ033016127 (DE-599)DOAJ8f959ced14dc422b904dbd3e9c1d7ce7 DE-627 ger DE-627 rakwb eng QD415-436 Morić Ivana verfasserin aut rRNA methyltransferases and their role in resistance to antibiotics 2010 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Methyltransferases (MTases), a large protein superfamily, commonly use S-adenosyl-L-methionine (SAM) as the methyl group donor. SAM-dependant MTases methylate both nucleic acids (DNA, RNA) and proteins, and thus modulate their activity, function and folding. Methylation of G1405 or A1408 nucleotides of 16S rRNA in aminoglycoside-producing microorganisms confers the resistance to their own toxic product(s). This mechanism of resistance has been considered as unique to antibiotics producers until recently. Since 2003, methylation of 16S rRNA as a mechanism of resistance is increasingly emerging in pathogenic bacteria. This represents a major threat towards the usefulness of aminoglycosides in the clinical practice. A potential solution to the problem involves the design of novel compounds that would act against new ribosomal targets. The second approach to the issue includes the development of resistance MTases' inhibitors, with the idea to prevent them from modifying the bacterial rRNA, and thus reinstate the therapeutic power of existing aminoglycosides. As the latter approach has considerable potential, it is obvious that fundamental research related to protein expression, in-depth understanding of the mechanism of action and resolving a tertiary structure of 16S rRNAs MTases are prerequisites for application in medicine. aminoglycosides methyltransferases resistance ribosome Biochemistry Savić Miloje verfasserin aut Ilić-Tomić Tatjana verfasserin aut Vojnović Sandra verfasserin aut Bajkić Sanja verfasserin aut Vasiljević Branka verfasserin aut In Journal of Medical Biochemistry Society of Medical Biochemists of Serbia, Belgrade, 2008 29(2010), 3, Seite 165-174 (DE-627)557575117 (DE-600)2405112-3 14528266 nnns volume:29 year:2010 number:3 pages:165-174 https://doaj.org/article/8f959ced14dc422b904dbd3e9c1d7ce7 kostenfrei https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2010/1452-82581003165M.pdf kostenfrei https://doaj.org/toc/1452-8258 Journal toc kostenfrei https://doaj.org/toc/1452-8266 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2027 GBV_ILN_2055 GBV_ILN_2111 AR 29 2010 3 165-174 |
allfields_unstemmed |
(DE-627)DOAJ033016127 (DE-599)DOAJ8f959ced14dc422b904dbd3e9c1d7ce7 DE-627 ger DE-627 rakwb eng QD415-436 Morić Ivana verfasserin aut rRNA methyltransferases and their role in resistance to antibiotics 2010 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Methyltransferases (MTases), a large protein superfamily, commonly use S-adenosyl-L-methionine (SAM) as the methyl group donor. SAM-dependant MTases methylate both nucleic acids (DNA, RNA) and proteins, and thus modulate their activity, function and folding. Methylation of G1405 or A1408 nucleotides of 16S rRNA in aminoglycoside-producing microorganisms confers the resistance to their own toxic product(s). This mechanism of resistance has been considered as unique to antibiotics producers until recently. Since 2003, methylation of 16S rRNA as a mechanism of resistance is increasingly emerging in pathogenic bacteria. This represents a major threat towards the usefulness of aminoglycosides in the clinical practice. A potential solution to the problem involves the design of novel compounds that would act against new ribosomal targets. The second approach to the issue includes the development of resistance MTases' inhibitors, with the idea to prevent them from modifying the bacterial rRNA, and thus reinstate the therapeutic power of existing aminoglycosides. As the latter approach has considerable potential, it is obvious that fundamental research related to protein expression, in-depth understanding of the mechanism of action and resolving a tertiary structure of 16S rRNAs MTases are prerequisites for application in medicine. aminoglycosides methyltransferases resistance ribosome Biochemistry Savić Miloje verfasserin aut Ilić-Tomić Tatjana verfasserin aut Vojnović Sandra verfasserin aut Bajkić Sanja verfasserin aut Vasiljević Branka verfasserin aut In Journal of Medical Biochemistry Society of Medical Biochemists of Serbia, Belgrade, 2008 29(2010), 3, Seite 165-174 (DE-627)557575117 (DE-600)2405112-3 14528266 nnns volume:29 year:2010 number:3 pages:165-174 https://doaj.org/article/8f959ced14dc422b904dbd3e9c1d7ce7 kostenfrei https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2010/1452-82581003165M.pdf kostenfrei https://doaj.org/toc/1452-8258 Journal toc kostenfrei https://doaj.org/toc/1452-8266 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2027 GBV_ILN_2055 GBV_ILN_2111 AR 29 2010 3 165-174 |
allfieldsGer |
(DE-627)DOAJ033016127 (DE-599)DOAJ8f959ced14dc422b904dbd3e9c1d7ce7 DE-627 ger DE-627 rakwb eng QD415-436 Morić Ivana verfasserin aut rRNA methyltransferases and their role in resistance to antibiotics 2010 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Methyltransferases (MTases), a large protein superfamily, commonly use S-adenosyl-L-methionine (SAM) as the methyl group donor. SAM-dependant MTases methylate both nucleic acids (DNA, RNA) and proteins, and thus modulate their activity, function and folding. Methylation of G1405 or A1408 nucleotides of 16S rRNA in aminoglycoside-producing microorganisms confers the resistance to their own toxic product(s). This mechanism of resistance has been considered as unique to antibiotics producers until recently. Since 2003, methylation of 16S rRNA as a mechanism of resistance is increasingly emerging in pathogenic bacteria. This represents a major threat towards the usefulness of aminoglycosides in the clinical practice. A potential solution to the problem involves the design of novel compounds that would act against new ribosomal targets. The second approach to the issue includes the development of resistance MTases' inhibitors, with the idea to prevent them from modifying the bacterial rRNA, and thus reinstate the therapeutic power of existing aminoglycosides. As the latter approach has considerable potential, it is obvious that fundamental research related to protein expression, in-depth understanding of the mechanism of action and resolving a tertiary structure of 16S rRNAs MTases are prerequisites for application in medicine. aminoglycosides methyltransferases resistance ribosome Biochemistry Savić Miloje verfasserin aut Ilić-Tomić Tatjana verfasserin aut Vojnović Sandra verfasserin aut Bajkić Sanja verfasserin aut Vasiljević Branka verfasserin aut In Journal of Medical Biochemistry Society of Medical Biochemists of Serbia, Belgrade, 2008 29(2010), 3, Seite 165-174 (DE-627)557575117 (DE-600)2405112-3 14528266 nnns volume:29 year:2010 number:3 pages:165-174 https://doaj.org/article/8f959ced14dc422b904dbd3e9c1d7ce7 kostenfrei https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2010/1452-82581003165M.pdf kostenfrei https://doaj.org/toc/1452-8258 Journal toc kostenfrei https://doaj.org/toc/1452-8266 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2027 GBV_ILN_2055 GBV_ILN_2111 AR 29 2010 3 165-174 |
allfieldsSound |
(DE-627)DOAJ033016127 (DE-599)DOAJ8f959ced14dc422b904dbd3e9c1d7ce7 DE-627 ger DE-627 rakwb eng QD415-436 Morić Ivana verfasserin aut rRNA methyltransferases and their role in resistance to antibiotics 2010 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Methyltransferases (MTases), a large protein superfamily, commonly use S-adenosyl-L-methionine (SAM) as the methyl group donor. SAM-dependant MTases methylate both nucleic acids (DNA, RNA) and proteins, and thus modulate their activity, function and folding. Methylation of G1405 or A1408 nucleotides of 16S rRNA in aminoglycoside-producing microorganisms confers the resistance to their own toxic product(s). This mechanism of resistance has been considered as unique to antibiotics producers until recently. Since 2003, methylation of 16S rRNA as a mechanism of resistance is increasingly emerging in pathogenic bacteria. This represents a major threat towards the usefulness of aminoglycosides in the clinical practice. A potential solution to the problem involves the design of novel compounds that would act against new ribosomal targets. The second approach to the issue includes the development of resistance MTases' inhibitors, with the idea to prevent them from modifying the bacterial rRNA, and thus reinstate the therapeutic power of existing aminoglycosides. As the latter approach has considerable potential, it is obvious that fundamental research related to protein expression, in-depth understanding of the mechanism of action and resolving a tertiary structure of 16S rRNAs MTases are prerequisites for application in medicine. aminoglycosides methyltransferases resistance ribosome Biochemistry Savić Miloje verfasserin aut Ilić-Tomić Tatjana verfasserin aut Vojnović Sandra verfasserin aut Bajkić Sanja verfasserin aut Vasiljević Branka verfasserin aut In Journal of Medical Biochemistry Society of Medical Biochemists of Serbia, Belgrade, 2008 29(2010), 3, Seite 165-174 (DE-627)557575117 (DE-600)2405112-3 14528266 nnns volume:29 year:2010 number:3 pages:165-174 https://doaj.org/article/8f959ced14dc422b904dbd3e9c1d7ce7 kostenfrei https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2010/1452-82581003165M.pdf kostenfrei https://doaj.org/toc/1452-8258 Journal toc kostenfrei https://doaj.org/toc/1452-8266 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2027 GBV_ILN_2055 GBV_ILN_2111 AR 29 2010 3 165-174 |
language |
English |
source |
In Journal of Medical Biochemistry 29(2010), 3, Seite 165-174 volume:29 year:2010 number:3 pages:165-174 |
sourceStr |
In Journal of Medical Biochemistry 29(2010), 3, Seite 165-174 volume:29 year:2010 number:3 pages:165-174 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
aminoglycosides methyltransferases resistance ribosome Biochemistry |
isfreeaccess_bool |
true |
container_title |
Journal of Medical Biochemistry |
authorswithroles_txt_mv |
Morić Ivana @@aut@@ Savić Miloje @@aut@@ Ilić-Tomić Tatjana @@aut@@ Vojnović Sandra @@aut@@ Bajkić Sanja @@aut@@ Vasiljević Branka @@aut@@ |
publishDateDaySort_date |
2010-01-01T00:00:00Z |
hierarchy_top_id |
557575117 |
id |
DOAJ033016127 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ033016127</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230307173709.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2010 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ033016127</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ8f959ced14dc422b904dbd3e9c1d7ce7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QD415-436</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Morić Ivana</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">rRNA methyltransferases and their role in resistance to antibiotics</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2010</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Methyltransferases (MTases), a large protein superfamily, commonly use S-adenosyl-L-methionine (SAM) as the methyl group donor. SAM-dependant MTases methylate both nucleic acids (DNA, RNA) and proteins, and thus modulate their activity, function and folding. Methylation of G1405 or A1408 nucleotides of 16S rRNA in aminoglycoside-producing microorganisms confers the resistance to their own toxic product(s). This mechanism of resistance has been considered as unique to antibiotics producers until recently. Since 2003, methylation of 16S rRNA as a mechanism of resistance is increasingly emerging in pathogenic bacteria. This represents a major threat towards the usefulness of aminoglycosides in the clinical practice. A potential solution to the problem involves the design of novel compounds that would act against new ribosomal targets. The second approach to the issue includes the development of resistance MTases' inhibitors, with the idea to prevent them from modifying the bacterial rRNA, and thus reinstate the therapeutic power of existing aminoglycosides. As the latter approach has considerable potential, it is obvious that fundamental research related to protein expression, in-depth understanding of the mechanism of action and resolving a tertiary structure of 16S rRNAs MTases are prerequisites for application in medicine.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">aminoglycosides</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">methyltransferases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">resistance</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">ribosome</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Biochemistry</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Savić Miloje</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ilić-Tomić Tatjana</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Vojnović Sandra</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Bajkić Sanja</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Vasiljević Branka</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Journal of Medical Biochemistry</subfield><subfield code="d">Society of Medical Biochemists of Serbia, Belgrade, 2008</subfield><subfield code="g">29(2010), 3, Seite 165-174</subfield><subfield code="w">(DE-627)557575117</subfield><subfield code="w">(DE-600)2405112-3</subfield><subfield code="x">14528266</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:29</subfield><subfield code="g">year:2010</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:165-174</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/8f959ced14dc422b904dbd3e9c1d7ce7</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2010/1452-82581003165M.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1452-8258</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1452-8266</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2027</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">29</subfield><subfield code="j">2010</subfield><subfield code="e">3</subfield><subfield code="h">165-174</subfield></datafield></record></collection>
|
callnumber-first |
Q - Science |
author |
Morić Ivana |
spellingShingle |
Morić Ivana misc QD415-436 misc aminoglycosides misc methyltransferases misc resistance misc ribosome misc Biochemistry rRNA methyltransferases and their role in resistance to antibiotics |
authorStr |
Morić Ivana |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)557575117 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
QD415-436 |
illustrated |
Not Illustrated |
issn |
14528266 |
topic_title |
QD415-436 rRNA methyltransferases and their role in resistance to antibiotics aminoglycosides methyltransferases resistance ribosome |
topic |
misc QD415-436 misc aminoglycosides misc methyltransferases misc resistance misc ribosome misc Biochemistry |
topic_unstemmed |
misc QD415-436 misc aminoglycosides misc methyltransferases misc resistance misc ribosome misc Biochemistry |
topic_browse |
misc QD415-436 misc aminoglycosides misc methyltransferases misc resistance misc ribosome misc Biochemistry |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Journal of Medical Biochemistry |
hierarchy_parent_id |
557575117 |
hierarchy_top_title |
Journal of Medical Biochemistry |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)557575117 (DE-600)2405112-3 |
title |
rRNA methyltransferases and their role in resistance to antibiotics |
ctrlnum |
(DE-627)DOAJ033016127 (DE-599)DOAJ8f959ced14dc422b904dbd3e9c1d7ce7 |
title_full |
rRNA methyltransferases and their role in resistance to antibiotics |
author_sort |
Morić Ivana |
journal |
Journal of Medical Biochemistry |
journalStr |
Journal of Medical Biochemistry |
callnumber-first-code |
Q |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2010 |
contenttype_str_mv |
txt |
container_start_page |
165 |
author_browse |
Morić Ivana Savić Miloje Ilić-Tomić Tatjana Vojnović Sandra Bajkić Sanja Vasiljević Branka |
container_volume |
29 |
class |
QD415-436 |
format_se |
Elektronische Aufsätze |
author-letter |
Morić Ivana |
author2-role |
verfasserin |
title_sort |
rrna methyltransferases and their role in resistance to antibiotics |
callnumber |
QD415-436 |
title_auth |
rRNA methyltransferases and their role in resistance to antibiotics |
abstract |
Methyltransferases (MTases), a large protein superfamily, commonly use S-adenosyl-L-methionine (SAM) as the methyl group donor. SAM-dependant MTases methylate both nucleic acids (DNA, RNA) and proteins, and thus modulate their activity, function and folding. Methylation of G1405 or A1408 nucleotides of 16S rRNA in aminoglycoside-producing microorganisms confers the resistance to their own toxic product(s). This mechanism of resistance has been considered as unique to antibiotics producers until recently. Since 2003, methylation of 16S rRNA as a mechanism of resistance is increasingly emerging in pathogenic bacteria. This represents a major threat towards the usefulness of aminoglycosides in the clinical practice. A potential solution to the problem involves the design of novel compounds that would act against new ribosomal targets. The second approach to the issue includes the development of resistance MTases' inhibitors, with the idea to prevent them from modifying the bacterial rRNA, and thus reinstate the therapeutic power of existing aminoglycosides. As the latter approach has considerable potential, it is obvious that fundamental research related to protein expression, in-depth understanding of the mechanism of action and resolving a tertiary structure of 16S rRNAs MTases are prerequisites for application in medicine. |
abstractGer |
Methyltransferases (MTases), a large protein superfamily, commonly use S-adenosyl-L-methionine (SAM) as the methyl group donor. SAM-dependant MTases methylate both nucleic acids (DNA, RNA) and proteins, and thus modulate their activity, function and folding. Methylation of G1405 or A1408 nucleotides of 16S rRNA in aminoglycoside-producing microorganisms confers the resistance to their own toxic product(s). This mechanism of resistance has been considered as unique to antibiotics producers until recently. Since 2003, methylation of 16S rRNA as a mechanism of resistance is increasingly emerging in pathogenic bacteria. This represents a major threat towards the usefulness of aminoglycosides in the clinical practice. A potential solution to the problem involves the design of novel compounds that would act against new ribosomal targets. The second approach to the issue includes the development of resistance MTases' inhibitors, with the idea to prevent them from modifying the bacterial rRNA, and thus reinstate the therapeutic power of existing aminoglycosides. As the latter approach has considerable potential, it is obvious that fundamental research related to protein expression, in-depth understanding of the mechanism of action and resolving a tertiary structure of 16S rRNAs MTases are prerequisites for application in medicine. |
abstract_unstemmed |
Methyltransferases (MTases), a large protein superfamily, commonly use S-adenosyl-L-methionine (SAM) as the methyl group donor. SAM-dependant MTases methylate both nucleic acids (DNA, RNA) and proteins, and thus modulate their activity, function and folding. Methylation of G1405 or A1408 nucleotides of 16S rRNA in aminoglycoside-producing microorganisms confers the resistance to their own toxic product(s). This mechanism of resistance has been considered as unique to antibiotics producers until recently. Since 2003, methylation of 16S rRNA as a mechanism of resistance is increasingly emerging in pathogenic bacteria. This represents a major threat towards the usefulness of aminoglycosides in the clinical practice. A potential solution to the problem involves the design of novel compounds that would act against new ribosomal targets. The second approach to the issue includes the development of resistance MTases' inhibitors, with the idea to prevent them from modifying the bacterial rRNA, and thus reinstate the therapeutic power of existing aminoglycosides. As the latter approach has considerable potential, it is obvious that fundamental research related to protein expression, in-depth understanding of the mechanism of action and resolving a tertiary structure of 16S rRNAs MTases are prerequisites for application in medicine. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2027 GBV_ILN_2055 GBV_ILN_2111 |
container_issue |
3 |
title_short |
rRNA methyltransferases and their role in resistance to antibiotics |
url |
https://doaj.org/article/8f959ced14dc422b904dbd3e9c1d7ce7 https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2010/1452-82581003165M.pdf https://doaj.org/toc/1452-8258 https://doaj.org/toc/1452-8266 |
remote_bool |
true |
author2 |
Savić Miloje Ilić-Tomić Tatjana Vojnović Sandra Bajkić Sanja Vasiljević Branka |
author2Str |
Savić Miloje Ilić-Tomić Tatjana Vojnović Sandra Bajkić Sanja Vasiljević Branka |
ppnlink |
557575117 |
callnumber-subject |
QD - Chemistry |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
callnumber-a |
QD415-436 |
up_date |
2024-07-03T15:21:56.210Z |
_version_ |
1803571813378162688 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ033016127</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230307173709.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230226s2010 xx |||||o 00| ||eng c</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ033016127</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJ8f959ced14dc422b904dbd3e9c1d7ce7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QD415-436</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">Morić Ivana</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">rRNA methyltransferases and their role in resistance to antibiotics</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2010</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Methyltransferases (MTases), a large protein superfamily, commonly use S-adenosyl-L-methionine (SAM) as the methyl group donor. SAM-dependant MTases methylate both nucleic acids (DNA, RNA) and proteins, and thus modulate their activity, function and folding. Methylation of G1405 or A1408 nucleotides of 16S rRNA in aminoglycoside-producing microorganisms confers the resistance to their own toxic product(s). This mechanism of resistance has been considered as unique to antibiotics producers until recently. Since 2003, methylation of 16S rRNA as a mechanism of resistance is increasingly emerging in pathogenic bacteria. This represents a major threat towards the usefulness of aminoglycosides in the clinical practice. A potential solution to the problem involves the design of novel compounds that would act against new ribosomal targets. The second approach to the issue includes the development of resistance MTases' inhibitors, with the idea to prevent them from modifying the bacterial rRNA, and thus reinstate the therapeutic power of existing aminoglycosides. As the latter approach has considerable potential, it is obvious that fundamental research related to protein expression, in-depth understanding of the mechanism of action and resolving a tertiary structure of 16S rRNAs MTases are prerequisites for application in medicine.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">aminoglycosides</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">methyltransferases</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">resistance</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">ribosome</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Biochemistry</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Savić Miloje</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Ilić-Tomić Tatjana</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Vojnović Sandra</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Bajkić Sanja</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Vasiljević Branka</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Journal of Medical Biochemistry</subfield><subfield code="d">Society of Medical Biochemists of Serbia, Belgrade, 2008</subfield><subfield code="g">29(2010), 3, Seite 165-174</subfield><subfield code="w">(DE-627)557575117</subfield><subfield code="w">(DE-600)2405112-3</subfield><subfield code="x">14528266</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:29</subfield><subfield code="g">year:2010</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:165-174</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/8f959ced14dc422b904dbd3e9c1d7ce7</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2010/1452-82581003165M.pdf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1452-8258</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1452-8266</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2027</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">29</subfield><subfield code="j">2010</subfield><subfield code="e">3</subfield><subfield code="h">165-174</subfield></datafield></record></collection>
|
score |
7.400069 |